Sanofi (NASDAQ: SNY) reported Q4 EPS of EUR1.71, EUR0.79 better than the analyst estimate of EUR0.92. Revenue for the quarter came in at EUR10.72 billion versus the consensus estimate of EUR12.2 billion.

For earnings history and earnings-related data on Sanofi (SNY) click here.